Healthcare provider profile · identity verified

Moisey Delman, MD

Allopathic & Osteopathic Physicians|Internal Medicine · REGO PARK, NY · NPI 1982665261

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Moisey Delman, MD received $22.62 in general payments during 2025 across 1 reported records.

E.R. Squibb & Sons, L.L.C. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 353 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$22.62

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
E.R. Squibb & Sons, L.L.C.	Unresolved — no canonical attribution shown	$22.62	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$22.62	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
COBENFY Normalized: cobenfy	Drug	E.R. Squibb & Sons, L.L.C.	$22.62	1	2025
Source payment records 2025-11-24 · E.R. Squibb & Sons, L.L.C. · $22.62 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713	Eliquis · 2024 Exact normalized brand match · 1 Part D row	353	40

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	446	69
Amlodipine Besylate	Amlodipine Besylate	396	68
Metformin Hcl	Metformin Hcl	378	53
Eliquis	Apixaban	353	40
Metoprolol Tartrate	Metoprolol Tartrate	299	44
Rosuvastatin Calcium	Rosuvastatin Calcium	295	61
Levothyroxine Sodium	Levothyroxine Sodium	288	39
Pantoprazole Sodium	Pantoprazole Sodium	281	58
Metoprolol Succinate	Metoprolol Succinate	275	50
Furosemide	Furosemide	264	45
Gabapentin	Gabapentin	264	50
Losartan Potassium	Losartan Potassium	257	45
Diclofenac Sodium	Diclofenac Sodium	251	39
Linzess	Linaclotide	239	32
Tamsulosin Hcl	Tamsulosin Hcl	229	32
Lactulose	Lactulose	226	18
Omeprazole	Omeprazole	215	52
Januvia	Sitagliptin Phosphate	197	19
Levetiracetam	Levetiracetam	194	20
Escitalopram Oxalate	Escitalopram Oxalate	188	26
Famotidine	Famotidine	176	26
Zenpep	Lipase/Protease/Amylase	154	17
Nystatin	Nystatin	151	21
Vascepa	Icosapent Ethyl	151	22
Spironolactone	Spironolactone	144	28
Albuterol Sulfate	Albuterol Sulfate	139	12
Hydrochlorothiazide	Hydrochlorothiazide	133	28
Lisinopril	Lisinopril	130	19
Carvedilol	Carvedilol	129	20
Sertraline Hcl	Sertraline Hcl	124	18
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	123	18
Mirtazapine	Mirtazapine	123	19
Clonazepam	Clonazepam	122	15
Clopidogrel	Clopidogrel Bisulfate	107	19
Doxazosin Mesylate	Doxazosin Mesylate	103	13
Simvastatin	Simvastatin	103	22
Ipratropium Bromide	Ipratropium Bromide	100	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	96	17
Tramadol Hcl	Tramadol Hcl	92	12
Finasteride	Finasteride	91	15
Esomeprazole Magnesium	Esomeprazole Magnesium	90	23
Divalproex Sodium	Divalproex Sodium	89	15
Clonidine Hcl	Clonidine Hcl	87	12
Fluticasone Propionate	Fluticasone Propionate	87	23
Hydralazine Hcl	Hydralazine Hcl	85	17
Azithromycin	Azithromycin	82	58
Ozempic	Semaglutide	82	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	79	16
Glimepiride	Glimepiride	78	11
Potassium Chloride	Potassium Chloride	77	13
Vitamin D2	Ergocalciferol (Vitamin D2)	76	12
Albuterol Sulfate Hfa	Albuterol Sulfate	70	20
Alprazolam	Alprazolam	67	17
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	66	suppressed
Enalapril Maleate	Enalapril Maleate	65	suppressed
Latanoprost	Latanoprost	64	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	63	13
Trazodone Hcl	Trazodone Hcl	59	11
Janumet	Sitagliptin Phos/Metformin Hcl	58	suppressed
Jardiance	Empagliflozin	56	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	15
Valproic Acid	Valproic Acid (As Sodium Salt)	54	suppressed
Dexilant	Dexlansoprazole	52	suppressed
Memantine Hcl	Memantine Hcl	52	12
Lorazepam	Lorazepam	51	11
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Ammonium Lactate	Ammonium Lactate	48	12
Donepezil Hcl	Donepezil Hcl	47	suppressed
Nystop	Nystatin	47	suppressed
Farxiga	Dapagliflozin Propanediol	46	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	45	suppressed
Incruse Ellipta	Umeclidinium Bromide	45	suppressed
Lidocaine	Lidocaine	45	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Olanzapine	Olanzapine	43	suppressed
Risperidone	Risperidone	43	suppressed
Atenolol	Atenolol	42	suppressed
Lacosamide	Lacosamide	42	suppressed
Nexium	Esomeprazole Magnesium	42	suppressed
Myrbetriq	Mirabegron	41	suppressed
Prednisone	Prednisone	41	15
Sodium Chloride	0.9 % Sodium Chloride	41	12
Breo Ellipta	Fluticasone/Vilanterol	40	suppressed
Dexlansoprazole Dr	Dexlansoprazole	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Ramipril	Ramipril	40	suppressed
Amiodarone Hcl	Amiodarone Hcl	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Labetalol Hcl	Labetalol Hcl	39	suppressed
Naproxen	Naproxen	39	18
Propranolol Hcl	Propranolol Hcl	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	21
Baclofen	Baclofen	37	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	36	suppressed
Nifedipine Er	Nifedipine	36	suppressed
Phenobarbital	Phenobarbital	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Meropenem	Meropenem	34	11
Ranolazine Er	Ranolazine	33	suppressed
Midodrine Hcl	Midodrine Hcl	32	suppressed
Icosapent Ethyl	Icosapent Ethyl	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Valsartan	Valsartan	31	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Tradjenta	Linagliptin	30	suppressed
Benztropine Mesylate	Benztropine Mesylate	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	11
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Hydrocortisone	Hydrocortisone	27	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	27	suppressed
Vancomycin Hcl	Vancomycin Hcl	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Glipizide	Glipizide	24	suppressed
Haloperidol	Haloperidol	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	11
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Procto-Med Hc	Hydrocortisone	23	suppressed
Carbamazepine	Carbamazepine	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Nitroglycerin Patch	Nitroglycerin	22	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	12
Diovan	Valsartan	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Mupirocin	Mupirocin	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Scopolamine	Scopolamine	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Methimazole	Methimazole	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Procrit	Epoetin Alfa	19	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	18	suppressed
Amantadine	Amantadine Hcl	17	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	17	suppressed
Retacrit	Epoetin Alfa-Epbx	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Lexapro	Escitalopram Oxalate	16	suppressed
Methylprednisolone	Methylprednisolone	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Topiramate	Topiramate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Restasis	Cyclosporine	15	suppressed
Cilostazol	Cilostazol	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Budesonide	Budesonide	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Crestor	Rosuvastatin Calcium	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	13	suppressed
Steglatro	Ertugliflozin Pidolate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	12	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lipitor	Atorvastatin Calcium	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Mesalamine Dr	Mesalamine	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$22.62 · 1 records	E.R. Squibb & Sons, L.L.C.	COBENFY	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error